EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Levofloxacin–Niflumate Salt Development as a Strategy for Improving Physicochemical Properties and Modulating Antibiotic Potency and Anti-Inflammatory Performance

Ilma Nugrahani, Hidehiro Uekusa iD, Takaaki Hori, Yutong Wu, Marlia Singgih Wibowo iD, Afrillia Nuryanti Garmana iD, Febrina Ester Panjaitan

Drug Design, Development and Therapy · 2025-06 · Volume 19 · 5311-5328

DOI: 10.2147/dddt.s515235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-06. Verfasst von Ilma Nugrahani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacochemistry, School of Pharmacy, Bandung Institute of Technology, Bandung, West Java, 40132, Indonesia. Hauptthemen laut MEDLINE: Levofloxacin, Anti-Bacterial Agents, Niflumic Acid, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This research aimed to develop and characterize a novel levofloxacin-niflumic acid salt, to improve its physicochemical properties, antibiotic potency, and anti-inflammatory effects.

Methods

A 1:1 molar ratio salt was synthesized and its crystal structure determined using single-crystal X-ray diffractometry (SCXRD) also characterized using powder X-ray diffractometry (PXRD), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FTIR). Scalability was evaluated via neat grinding, solvent-dropped grinding, hot melt mixing, and slurry techniques. Stability under controlled conditions (70-80%RH/25-30°C) was assessed using PXRD, DSC, and HPLC solubility measurements, levofloxacin's antibiotic potency (microdilution), and niflumic acid's anti-inflammatory activity (in vivo in Wistar rats) were also evaluated.

Results

SCXRD confirmed the formation of a stable multicomponent salt, levofloxacin-niflumate. The slurry method successfully yielded a homogeneous powder with identical structural characteristics to the single crystal. Notably, the salt demonstrated enhanced physical and chemical stability compared to the individual drugs and their physical mixture. The solubility of niflumic acid was significantly increased, and the salt formation positively influenced both levofloxacin's antibiotic potency and niflumic acid's anti-inflammatory activity.

Conclusion

The successful development of the levofloxacin-niflumate salt offers a promising strategy to improve the stability and potency of levofloxacin, along with enhanced niflumic acid solubility that contributes to improved anti-inflammatory action. This enhanced profile suggests the potential for more effective and efficient therapeutic use, which could improve patient compliance given the frequent co-prescription of these drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinAnti-Bacterial AgentsNiflumic AcidAnti-Inflammatory Agents, Non-SteroidalAnti-Inflammatory AgentsAnimalsRatsRats, WistarSolubilityMicrobial Sensitivity TestsMaleSaltsEdemaMolecular Structure

Stichwörter der Autor:innen

anti-inflammatory activityantimicrobial potencylevofloxacinmulticomponent saltniflumic acidstability

Substanzen

LevofloxacinAnti-Bacterial AgentsNiflumic AcidAnti-Inflammatory Agents, Non-SteroidalAnti-Inflammatory AgentsSalts

Autor:innen und Institutionen

  • Department of Pharmacochemistry, School of Pharmacy, Bandung Institute of Technology, Bandung, West Java, 40132, Indonesia.
  • Department of Chemistry, School of Science, Institute of Science Tokyo, Tokyo, 152-8551, Japan.
  • Department of Pharmacology, School of Pharmacy, Bandung Institute of Technology, Bandung, West Java, 40132, Indonesia.

ORCID-Profile: Hidehiro Uekusa, Marlia Singgih Wibowo, Afrillia Nuryanti Garmana

Zitieren

APA

Nugrahani, I., Uekusa, H., Hori, T., Wu, Y., Wibowo, M. S., Garmana, A. N., & Panjaitan, F. E. (2025). Levofloxacin–Niflumate Salt Development as a Strategy for Improving Physicochemical Properties and Modulating Antibiotic Potency and Anti-Inflammatory Performance. Drug Design, Development and Therapy, Volume 19, 5311-5328. https://doi.org/10.2147/dddt.s515235

Vancouver

Nugrahani I, Uekusa H, Hori T, Wu Y, Wibowo MS, Garmana AN, et al. Levofloxacin–Niflumate Salt Development as a Strategy for Improving Physicochemical Properties and Modulating Antibiotic Potency and Anti-Inflammatory Performance. Drug Design, Development and Therapy. 2025;Volume 19:5311-5328. doi:10.2147/dddt.s515235

BibTeX
@article{Nugrahani2025,
  author = {Nugrahani, Ilma and Uekusa, Hidehiro and Hori, Takaaki and Wu, Yutong and Wibowo, Marlia Singgih and Garmana, Afrillia Nuryanti and Panjaitan, Febrina Ester},
  title = {Levofloxacin–Niflumate Salt Development as a Strategy for Improving Physicochemical Properties and Modulating Antibiotic Potency and Anti-Inflammatory Performance},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {5311--5328},
  doi = {10.2147/dddt.s515235}
}
Kostenlos starten →